IceCure Medical said today that it has signed Terumo (OTC:TRUMY;TYO:4543) as the exclusive distributor of its tumor-freezing technology in Japan and Singapore. Terumo will pay IceCure $2 million for the distro rights if IceCure obtains the appropriate regulatory approvals for its ProSense cryoablation device, designed to treat malignant breast tumors without surgery. This will include […]
Niowave raises $3m in equity funding
Niowave raised $3 million in equity funding, company CFO Mike Zamiara confirmed after the company filed an SEC Form D this week. Zamiara told MassDevice.com via email that the funding “allows us to continue to develop our medical isotope program,” while it also will help the company meet its match requirement for a grant from […]
Varian closes $90m microspheres buy from Boston Scientific
Hot on the heels of the $4 billion buyout of BTG by Boston Scientific (NYSE:BSX), Varian (NYSE:VAR) said yesterday that it closed the $90 million acquisition of Boston’s microspheres business. The deal for the drug-eluting and “bland” embolic microsphere business, which includes the Oncozene, Embozene and Embozone Tandem products, was struck to mollify anti-trust regulators about the BTG […]
Delcath Systems raises another $9.5m
Delcath Systems (OTC:DCTH) has closed on a $9.5 million private placement round, bringing the total amount raised since July to $29.5 million. The Queensbury, N.Y.-based company priced the round at $1,000 per unit, with each unit consisting of a preferred convertible share worth 16,667 common shares, at a 6¢ strike price, and a five-year warrant for […]
Check-Cap, GE Healthcare close manufacturing line transfer
Check-Cap (NSDQ:CHEK) said it finalized a manufacturing line transfer implementation and qualification with the healthcare business at General Electric (NYSE:GE) for its C-Scan system, a preparation-free ingestible scanning capsule-based system designed to prevent colorectal cancer. The C-Scan system is in the midst of a pilot clinical trial at the New York University School of Medicine and […]
Lumicell closes enrollment of feasibility trial
Lumicell said it completed enrollment in a Phase C feasibility clinical trial for its intraoperative breast cancer imaging system. The Newton, Mass.-based company expects results later this year and plans to start a pivotal trial by the end of 2019 before it applies for FDA approval. Lumicell’s imaging system is designed to enable surgeons to […]
Novocure’s Optune wins innovative medical device designation from China
NovoCure (NSDQ:NVCR) said today that it was granted Innovative Medical Device Designation in China for its Optune tumor treating system. The Optune system uses electric fields that are tuned in to specific frequencies to disrupt cancer cell division, according to the company. The technology inhibits tumor growth and causes cancer cells to die. Zai Lab has […]
IceCure Medical wins Israeli AMAR approval for tumor freezing technology
IceCure Medical yesterday said it received Israeli AMAR authorization to use its freezing technology in specific indications. The approval will allow the Israel-based company to use the technology to freeze benign and malignant tumors, including breast, lungs, bones, liver, lymphatic tissue, lymph nodes and endocrine glands. “This specific approval in Israel is an important achievement […]
Delcath Systems closes $20m private placement
Delcath Systems (OTC:DCTH) last week said that it closed a $20 million private placement round for the liver cancer treatment it developed. The Queensbury, N.Y.-based company priced the round at $1,000 per unit, with each unit consisting of a preferred convertible share worth 16,667 common shares, at a 6¢ strike price, and a five-year warrant another […]
AirXpanders abruptly pulls the plug
AirXpanders (ASX:AXP) abruptly pulled the plug yesterday, saying it plans to lay off nearly all its employees and file for Chapter 7 bankruptcy by the end of the month. The Palo Alto, Calif.–based company makes the AeroForm device for post-mastectomy breast reconstruction. It’s designed to expand and stretch the skin and underlying muscle prior to […]
Australia eyes ban on textured breast implants
Australia’s TGA said last week that it concluded breast implants do not need to be removed as breast implant-associated anapestic large cell lymphoma (BIA-ALCL) is rare. The regulatory body said in April that is was considering implementing a ban on textured breast implants and was seeking new data from suppliers of the implants to decide […]
- 1
- 2
- 3
- …
- 77
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube